These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 2434787)
1. Effects of intravenous ketanserin on severely hypertensive patients with double-blind crossover assessment of central side-effects. Jennings AA; Opie LH J Cardiovasc Pharmacol; 1987 Jan; 9(1):120-4. PubMed ID: 2434787 [TBL] [Abstract][Full Text] [Related]
2. Ketanserin in parenteral treatment of acute essential hypertension: a dose-response curve. Milei J; Lemus J; Schiavone M; Lucioni MC J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S96-100. PubMed ID: 2446083 [TBL] [Abstract][Full Text] [Related]
3. Ketanserin, hypertension, and chronic alcoholism: double-blind study in forty patients. de Lorenzo A; Ceccanti M; Assogna G; Romeo M; Cavaleri G; Attilia ML Int J Clin Pharmacol Res; 1988; 8(5):321-5. PubMed ID: 3068159 [TBL] [Abstract][Full Text] [Related]
4. Greater reduction of urinary albumin excretion in hypertensive type II diabetic patients with incipient nephropathy by lisinopril than by nifedipine. Agardh CD; Garcia-Puig J; Charbonnel B; Angelkort B; Barnett AH J Hum Hypertens; 1996 Mar; 10(3):185-92. PubMed ID: 8733038 [TBL] [Abstract][Full Text] [Related]
5. Sublingual and intravenous ketanserin versus sublingual nifedipine in the treatment of severe hypertension: a randomized study. Sechi LA; Tedde R; Cassisa L; Pala A; Orecchioni C; Uneddu F; Melis A Clin Ther; 1989; 11(6):834-40. PubMed ID: 2692825 [TBL] [Abstract][Full Text] [Related]
6. Long-term antihypertensive efficacy of ketanserin plus chlorthalidone. Fasano ML; Soro S; Ferrara LA Drugs Exp Clin Res; 1989; 15(11-12):587-90. PubMed ID: 2700322 [TBL] [Abstract][Full Text] [Related]
7. A double-blind comparative study of ketanserin with atenolol in essential hypertension. Antonicelli R; Andreoni A; Saccomanno G; Gambini C; Paciaroni E Drugs Exp Clin Res; 1989; 15(11-12):577-81. PubMed ID: 2700320 [TBL] [Abstract][Full Text] [Related]
8. Clinical aspects during therapy with the serotonin antagonist ketanserin. Distler A Clin Physiol Biochem; 1990; 8 Suppl 3():64-80. PubMed ID: 1983424 [TBL] [Abstract][Full Text] [Related]
9. Multicenter study with ketanserin in essential hypertension: an Argentine experiment. Demartini A; Pezzano R; Bernardiner E; Torres J; Genta C; Scheijgrond H; Gypen L J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S135-7. PubMed ID: 2446062 [TBL] [Abstract][Full Text] [Related]
10. Antihypertensive mechanism of ketanserin in postoperative hypertension after cardiopulmonary bypass. Anger C; Carter JA; Prys-Roberts C Anesth Analg; 1988 Feb; 67(2):99-106. PubMed ID: 3277483 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study. Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306 [TBL] [Abstract][Full Text] [Related]
12. Blood pressure reduction and pharmacokinetics of ketanserin in hypertensive patients. Hedner T; Pettersson A; Persson B J Hypertens Suppl; 1986 Apr; 4(1):S91-3. PubMed ID: 2939221 [TBL] [Abstract][Full Text] [Related]
13. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study. Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367 [TBL] [Abstract][Full Text] [Related]
14. [Evaluation of acute and chronic effects of ketanserin in the treatment of hypertension and hypothesis on a new mechanism of action]. Sechi LA Ann Ital Med Int; 1990; 5(4 Pt 2):433-50. PubMed ID: 2102130 [TBL] [Abstract][Full Text] [Related]
15. Ketanserin versus propranolol in the treatment of mild and moderate essential hypertension: corroboration with ambulatory blood pressure monitoring. Novo S; Alaimo G; Giordano U; Raineri A; Strano A J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S104-6. PubMed ID: 2446055 [TBL] [Abstract][Full Text] [Related]
16. Ketanserin in mild to moderate hypertension in the elderly: a double-blind study versus methyldopa. Cattin L; Da Col PG Clin Ther; 1989; 11(3):363-72. PubMed ID: 2663164 [TBL] [Abstract][Full Text] [Related]
17. Serotonin antagonism in the treatment of cardiac insufficiency. Brune S; Tebbe U; Kreuzer H Clin Physiol Biochem; 1990; 8 Suppl 3():85-9. PubMed ID: 2132178 [TBL] [Abstract][Full Text] [Related]
18. Clinical experience with ketanserin in the treatment of hypertension. Palermo A; Mara G; Pizza N; Costantini C; del Rosso G; Assogna G; Libretti A J Hypertens Suppl; 1986 Apr; 4(1):S81-3. PubMed ID: 2939219 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial. Sramek JJ; Leibowitz MT; Weinstein SP; Rowe ED; Mendel CM; Levy B; McMahon FG; Mullican WS; Toth PD; Cutler NR J Hum Hypertens; 2002 Jan; 16(1):13-9. PubMed ID: 11840225 [TBL] [Abstract][Full Text] [Related]
20. A double-blind, placebo-controlled, crossover trial to investigate the additive hypotensive effect of a diuretic (mefruside) to that produced by nifedipine. Poulter N; Thompson AV; Sever PS J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S53-6. PubMed ID: 2455140 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]